title: Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody.
abstract: Because of its short physical half life, the use of anti-tumor antibodies radiolabeled with 99mTc has necessitated early (i.e. 2-6 h post-administration) imaging. It is possible that at these early times localization of antibodies in certain tumors may be largely due to non-specific processes. If so, other proteins or agents may be preferred for early imaging of solid tumors. We have investigated tumor localization with labeled biotin administered subsequent to unlabeled and unconjugated streptavidin. Nude mice bearing anti-CEA tumors (LS174T) received 10 micrograms of 111In-labeled anti-CEA antibody (C110) or 111In-labeled streptavidin with sacrifice 5 h later. In an examination of pretargeting, other animals received 50 micrograms of unlabeled streptavidin followed 3 h later with 1 micrograms of 111In-labeled biotin (EB1) and sacrifice 2 h later. The biodistribution of labeled streptavidin was similar to that of labeled specific antibody except for lower blood and higher kidney levels. Tumor levels were also lower with labeled streptavidin but, because of still lower levels in liver and blood, the tumor/normal tissue ratios were improved. When unlabeled streptavidin was administered and followed by labeled biotin (pretargeting), tumor levels were further reduced modestly; however, normal tissue levels were greatly reduced such that the tumor/blood and tumor/liver ratios were 10.6 and 2.2 vs 1.5 and 0.5 for the specific antibody. Improvements were seen in all tissues sampled with the exception of kidney and muscle. A further control of labeled biotin alone (without the preinjection of streptavidin) showed minimal accumulations in all tissues with the exception of kidneys.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Nuclear Medicine, University of Massachusetts Medical Center, Worcester 01655.
authors.forename: D J
authors.initials: DJ
authors.lastname: Hnatowich
authors.forename: B
authors.initials: B
authors.lastname: Fritz
authors.forename: F
authors.initials: F
authors.lastname: Virzi
authors.forename: G
authors.initials: G
authors.lastname: Mardirossian
authors.forename: M
authors.initials: M
authors.lastname: Rusckowski
mesh_terms: D000818:Animals; D000912:Antibodies, Neoplasm / Q000378:metabolism; D001426:Bacterial Proteins / Q000493:pharmacokinetics; D001710:Biotin / Q000493:pharmacokinetics; D007205:Indium Radioisotopes; D051379:Mice; D008819:Mice, Nude; D009374:Neoplasms, Experimental / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000378:metabolism; D011877:Radionuclide Imaging; D019809:Streptavidin; D014018:Tissue Distribution
chemical_list: D000912:Antibodies, Neoplasm; D001426:Bacterial Proteins; D007205:Indium Radioisotopes; D001710:Biotin; D019809:Streptavidin